Asymmetric Calcification in Rheumatic Mitral Stenosis and Implications for Balloon Valvuloplasty

Ilya Karagodin1, Eric Kruse1, John E A Blair1

  • 1Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, IL.

JACC. Case Reports
|June 10, 2020
PubMed

Insights

Percutaneous balloon valvuloplasty effectively treated severe mitral stenosis in a high-risk patient. However, the procedure led to a commissural tear and moderate mitral regurgitation, indicating potential complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severe rheumatic mitral stenosis poses significant risks for surgical intervention.
  • Percutaneous balloon valvuloplasty offers an alternative treatment for carefully selected high-risk patients.
  • Mitral stenosis management requires careful consideration of procedural risks and benefits.

Purpose of the Study:

  • To evaluate the efficacy and complications of percutaneous balloon valvuloplasty in a patient with severe rheumatic mitral stenosis.
  • To assess the impact of the procedure on trans-mitral gradient and patient symptoms.
  • To document procedural complications, specifically commissural tears and induced mitral regurgitation.

Main Methods:

  • Percutaneous balloon valvuloplasty was performed for severe rheumatic mitral stenosis.
  • Trans-mitral gradient was measured before and after the procedure.
  • Patient symptoms were assessed pre- and post-intervention.
  • Echocardiography was used to evaluate for complications, including mitral regurgitation and structural damage.

Main Results:

  • The procedure successfully reduced the trans-mitral gradient.
  • Significant improvement in the patient's symptoms was observed post-valvuloplasty.
  • A tear in the posteromedial commissure occurred during the procedure.
  • Moderate mitral regurgitation was identified as a complication.

Conclusions:

  • Percutaneous balloon valvuloplasty can be an effective treatment for severe mitral stenosis in high-risk surgical candidates.
  • Careful monitoring for complications such as commissural tears and mitral regurgitation is crucial after the procedure.
  • The findings highlight the trade-offs between procedural success and potential iatrogenic complications in interventional cardiology.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
248
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
163
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
138
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
198
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
322
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
321